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Background: Few studies demonstrate effectiveness of therapies for oral rehabilitation of patients with cerebral palsy
(CP), given the difficulties in chewing, swallowing and speech, besides the intellectual, sensory and social limitations.
Due to upper airway obstruction, they are also vulnerable to sleep disorders. This study aims to assess the sleep
variables, through polysomnography, and masticatory dynamics, using electromiography, before and after
neuromuscular electrical stimulation, associated or not with low power laser (Gallium Arsenide- Aluminun, =780 nm)
and LED (= 660 nm) irradiation in CP patients.
Methods/design: 50 patients with CP, both gender, aged between 19 and 60 years will be enrolled in this study. The
inclusion criteria are: voluntary participation, patient with hemiparesis, quadriparesis or diparetic CP, with ability to
understand and respond to verbal commands. The exclusion criteria are: patients undergoing/underwent orthodontic,
functional maxillary orthopedic or botulinum toxin treatment. Polysomnographic and surface electromyographic exams
on masseter, temporalis and suprahyoid will be carry out in all sample. Questionnaire assessing oral characteristics will
be applied. The sample will be divided into 5 treatment groups: Group 1: neuromuscular electrical stimulation; Group 2:
laser therapy; Group 3: LED therapy; Group 4: neuromuscular electrical stimulation and laser therapy and Group 5:
neuromuscular electrical stimulation and LED therapy. All patients will be treated during 8 consecutive weeks. After
treatment, polysomnographic and electromiographic exams will be collected again.
Discussion: This paper describes a five arm clinical trial assessing the examination of sleep quality and masticatory
function in patients with CP under non-invasive therapies.
Trial registration: The protocol for this study is registered with the Brazilian Registry of Clinical Trials - ReBEC RBR-994XFS
Descriptors: Cerebral Palsy. Stomatognathic System. Electromyography. Transcutaneous Electric Nerve Stimulation.
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Cerebral palsy (CP) refers to disorders of motor develop-
ment, rising from the primary brain injury, are permanent
and changeable character, causing secondary musculoskel-
etal abnormalities and limitations in activities [1]. Recent
studies estimate the prevalence of this condition in 2,4 per
1000 children, which means a significant number of
people with this kind of disturbances [2].
Currently, the children with CP are classified according
to their functional independence in gross motor function.
Through Gross Motor Function Classification System
(GMFCS) for CP [3], the classification is by age (0–2, 2–4,
4–6, e 6–12 years), in five functional levels. The system
goal is to classify gross motor function with emphasis on
the movements of "sit" and "walk" [4-6]. Children who
have motor function problems similar to those classified
at level 1, can generally walk without restrictions but tend
to be limited in some of the more advanced motor skills.
Children classified at level 5, are usually very limited in
their ability to move even with the use of assistive [6].
It is known that the main alteration present in children
with CP is the motor impairment, which causes several
modifications rose from encephalopathy, with consequent
changes in body biomechanics. In addition, the child may
have intellectual disorders, sensitive, visual and hearing,
which added to the motor changes, task constraints and
the environment, have repercussions in different ways in
their functional performance [3,7-11].
Besides the difficulties in locomotion previously described,
as a result of the lack of motor coordination, orofacial altera-
tions are also common in these individuals. These disorders
are followed by pain, joint noise and irregular or deviated
jaw function [12]. Individuals with spastic muscles present
severely compromised function due to a diminished range
of motion, diminished voluntary strength, and increased
joint stiffness [13].
In general, important functions such as mastication,
speech and swallowing are compromised, due to tongue
thrusting, cheeks and lips incompetence, resulting in salivary
incompetence, presence involuntary bite reflex, asymmetric
positioning of the neck, making it difficult to maintain the
posture of the head, as well as lack of dynamic balance of
the masticatory muscles [14-16]. Some therapies may be
suggested to treat muscular alteration in CP, such as elec-
trical stimulation, LED therapy and laser therapy [17,18].
Neuromuscular electrical stimulation has been proposed as
a potentially useful modality for muscle strengthening in
children with CP. The electrical neuromuscular stimulation,
it is the application of electrical stimulation of sufficient in-
tensity to produce a visible muscle contraction which is ap-
plied to the motor point of the muscle, in order to promote
muscle strengthening. However, none study that analyzed
and compared their effectiveness in adult patients with CP
was found so far. Considering the relation between thefunction of masticatory muscles and the craniofacial com-
plex, the electromyographyc analysis (EGM) is an important
tool for the undestanding of muscular pattern when devel-
opmental and functional alterations are present [19]. Evalu-
ating and treating patients with special needs requires a
multidisciplinary approach. In this context, it is important to
consider that individuals with CP are also predisposed to
sleep-disordered breathing, such as obstructive sleep apnea
(OSA), which is one of the most common respiratory disor-
ders. Besides, it could occur oxyhemoglobin desaturation,
altered sleep-wake cycle, insomnia, disruption of sleep archi-
tecture, thus, resulting in hypoxia events during sleep.
Patients with CP have a higher prevalence ranging between
50–60% of sleep-disordered breathing, when compared to
individuals without CP. Health professionals should then
consider the obstruction of the upper airway during wake-
fulness and sleep in these patients, since in most cases, OSA
is not diagnosed [20-22]. In addition, sleep disorder leads to
an impairment on mood, behavior, and neurocognitive func-
tion and, along with pre-existing problems in patients with
PC, causes greater damage in their quality of life [20]. The
measurement of sleep quality and the evaluation of sleep
disorders in patients with PC are very important for the as-
sessment of these individuals holistically, and should be
added to the protocol for treating these patients. There is
much to clarify about the physiology of the impact of sleep
and its disorders, both in normal subjects and in patients
with special needs. Forward studies are needed to search for
an effective treatment protocol for improvement of quality
of life of these individuals.Aims and hypotheses
This study aims to assess the sleep variables and masticatory
dynamics by means of PSG and EMG, respectively, prior
and after neuromuscular electrical stimulation, associated or
not with low power laser irradiation (Gallium Arsenide-
Aluminun, = 780 nm) and LED (= 660 nm) in patients with
cerebral palsy. It is expected that Laser e LED biostimulation
will promote the morphophysiologic recovering of muscle
fibers and the decreasing of inflammatory process that will
be observed through the achievement of muscular physi-
ology within normal patterns established in this study. It is
hypothesized that oxyhemoglobin desaturation, caused by
pauses in breathing during sleep, can lead to harmful func-
tion in neuromuscular system in individuals with CP. We
also hypothesize that electrical stimulation, led therapy and
laser therapy will contribute to balance the muscular func-
tion, adjusting to physiologic patterns of muscular activity,
in rest and isometric positions [17,18]. The sample will be
divided according the randomization rules, in 5 groups with
10 patients (G1,G2,G3,G4,G5). In the G1 will be applied the
electrical stimulation, in the G2 laser therapy, in the G3 led
therapy, in the G4 the association of led therapy and
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therapy and electrical stimulation.
Methods/design
This is a randomized, five arms clinical trial [Figure 1]
conducted according to the ethical standards established in
the 1961 Declaration of Helsinki (as revised in Hong Kong
in 1989 and in Edimburgh, Scotland in 2000). This study is
registered with the World Health Organization Universal
Trial Number (UTN) U1111-1123-7969, and Registro
Brasileiro de Ensaios Clínicos (RBR-994xfs), and has been
approved by the Human Research Ethics Committees of the
Universidade Estadual Julio de Mesquita Filho, Sao Jose dos
Campos, Brazil (process number 25000.058696/2010-74).
All caregivers gave written, informed consent.
Subjects
Adult individuals between 19 and 60 years old with CP
will be recruited from the Training Program in Dentistry
for Persons with Disabilities, Department of Biosciences
and Oral Diagnosis, School of Dentistry, São Paulo State
University, Sao Jose dos Campos, SP, Brazil.
It will be included hemiparetic, quadriparetic or
diparetic CP subjects, with partially preserved cognitive
function, ability to respond to verbal commands, and
informed consent signed by patient or patient’s respon-
sible to voluntary participate in the study. The exclusion
criteria are patients underwent to orthodontic or functionalFigure 1 Flowchart of the study protocol.maxillary orthopedic treatment and therapies to reduce
spasticity (eg. botulinum toxin) at least 6 months before the
study.
Randomization
After the evaluation of the eligibility criteria, the subjects
will be randomly distributed into the five intervention
groups. Randomization numbers will be generated using
envelopes which will contain a card stipulating to which
group the subject will be allocated. It will be used sealed
and opaque envelopes to ensure confidentiality.
Sample size
The sample size, obtained by means of statistical power
analysis revealed that with 10 subjects in each group, an
90% power to detect a clinically relevant difference
would be present at the alpha level of 0.05.
Study interventions
Clinical evaluation of oromotor functions
Anamnesis will be obtained in order to assess chief com-
plaint, onset, frequency, evolution of the problem, con-
sulted professionals, treatments, results and prescription
of drugs, medical and family history, parafunctional
habits and psychogenic aspects.
A specific part of the questionnaire will approach sleep
breathing disorders, including snoring, choking during
sleep, drooling, nightmare experience, movement during
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dental occlusion, tooth wear, tooth loss, Mallampati evalu-
ation [23] and tonsils classification [24] will be evaluated.
Subjects will also be classified according to the five levels
of Gross Motor Function Classification System [3]. It is
emphasized that oropharyngeal alterations presented in
patients with CP will be reviewed by a speech therapist. A
modified scale of orofacial motor function assessment for
adults with CP, based on Santos [25], will be used, in order
to evaluate oral motor function, by performing simple
movements such as coordination and performance of
voluntary facial muscles, jaw protrusion and lateral move-
ment, tongue movements, such as elevation and laterality,
lip muscle strength (puff-out cheeks/maintain pressure),
glossopharyngeal/hypoglossal motor activity and rapid
coordinated jaw, lip, tongue and palatal movement.
According to the ability of the patient to perform properly
or not each movement, it will be applied the score 0
(inability to perform the movement) to 2 (ability to
complete the movement). The sum of scores for each item
will result in the total value of the patient´s oromotor
function.
Surface electromyography
For the EMG record, it will be used an eight-channel elec-
tromyography equipment (EMG-800 C, EMG System of
Brazil Ltda, Sao Jose dos Campos, SP) [Figure 2], previ-
ously calibrated with amplification of 2000 times and
16-bit resolution. Six input channels will be used to assess
the following muscles: channel 1 - anterior portion of
right temporalis muscle, channel 2 - superficial portion of
right masseter; channel 3 - anterior portion of left tempor-
alis muscle; channel 4 - superficial portion of the left mas-
seter, channel 5 - right suprahyoid muscles; and channel 6
- left suprahyoid muscles. The other two channels will be
used for the force transducer and mandibular goniometer.
Bipolar, small, passive, circular and disposable Ag/AgC
surface electrodes (MeditraceW Kendall-LTP, Chicopee,
MA) will be used for evaluation of masticatory system
activity. A reference electrode will be positioned in the
patient´s right wrist to reduce undesirable interferences of
the electromyographic signal. Volunteers will remain
seated, with natural head position during sEMG exam.
Electromyographic signals will be recorded after cleaning
the skin with 70% alcohol to reduce skin impedance and
to allow proper placement of surface electrodes. Surface
electrodes will be bilaterally placed according to anatom-
ical references and procedures guided by the direction of
muscle fibers in three points, the anterior temporal
muscle – 2 to 3 cm superior-posterior distant to the lat-
eral corner of the eyes in the region of greatest evidence
of muscle mass, no hair, parallel to the muscle fibers, but
with its sensing surface perpendicularly oriented; the
superficial portion of masseter – 1 to 2 cm above thegonial angle of the mandible, in the region of greatest evi-
dence of muscle mass, with muscle fibers parallel to the
surface, and supra-hyoid muscles – in the region of great-
est evidence of muscle mass, parallel to the muscle fibers
[26] [Figure 3].
Analysis of sEMG data
The average data will be expressed in RMS (Root Mean
Square) which qualitatively expresses the record of elec-
trical activity of muscles under study [27].
Protocol for electromyographic examination
It will be used a mandibular force transducer (EMG System
of Brazil Ltda, Sao Jose dos Campos, SP) [Figure 4] to record
the maximum bite force, which consists of a mechanical de-
vice with sensors that record material deformations during
the bite. This deformation is converted into kgf or Newton
by means of EMGLab V1.1 software (EMG System of Brazil
Ltda). In order to measure the mouth opening amplitude, it
will be adopted a mandibular goniometer (EMG System do
Brazil Ltda, Sao Jose dos Campos, SP) [Figure 5]. The elec-
tromyographic recordings will be performed in all phases of
the study, described below, in the rest position, isometric
position, bite force, using a transducer, and opening/closing
with the aid of the mandibular goniometer. Each EMG
recording will last ten seconds with an interval of one mi-
nute and will be repeated three times at the same appoint-
ment [28].
Phases of electromyographic exam
The sEMG, referring to the masseter, temporallis, supra-
hyoid, bite force and range of mandibular opening shall
be provided in four distinct phases. Phase 1- initial data
collection (Groups 1 to 5); Phase 2- treated groups
(Groups 1 to 5) after 1 week of electrical stimulation
with or without laser and LED therapy; Phase 3-treated
groups (Groups 1 to 5) after 4 week of electrical stimula-
tion with or without laser and LED therapy and Phase 4-
treated groups (Groups 1 to 5) after 8 weeks after the
last electrical stimulation with or without laser and LED
therapy.
Data obtained will be compared among each group to
verify the effectiveness of the proposed therapies to im-
prove the masticatory muscle activity in patients with CP.
Protocol for laser and LED therapy
After the evaluation and diagnosis, patients will be ran-
domly divided into 5 groups (n = 10). Groups 2 to 5 will
be treated with lasertherapy or LED theraphy, combined
or not with electricalstimulation twice a week for eight
consecutive weeks, following the protocol of [29].
The craniofacial complex will be irradiated in 12 areas,
being 1. posterior region of the temporomandibular joint
(TMJ) with open mouth, reaching the auriculo temporal
Figure 2 Electromyography equipment used in this study.
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the lateral pterygoid muscle (upper beam) at the neck of
the condyle and disk; 3. articular interface between con-
dyle and fossa with open mouth; 4. angle of the jaw; 5. an-
terior temporal muscle; 6. middle portion of the temporal
muscle; 7. posterior portion of the temporal muscle; 8.Figure 3 Electrodes placement.upper, middle and bottom of the sternocleidomastoid
muscle; 9. anterior portion of occipitofrontal muscle; 10.
posterior portion of the occipitofrontal muscle; 11. super-
ficial portion of the masseter; and 12. supra-hyoid mus-
cles. In groups 2 and 4, these anatomical structures will be
irradiated with a laser diode of gallium arsenide and
Figure 4 Mandibular force transducer equipment used in this
study.
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emitting at a wavelength of 660 nm, with a constant power
40 mW, and a maximum beam diameter of 0.38 cm2.
Groups 3 and 5 will be irradiated with a light emitting
diode (LED), emitting a wavelength band of 630± 5 nm,
with a constant power 40 mW, and the maximum laser
beam diameter of 0.38 cm2. Both will be operated in
continuous mode and should be used in contact with the
target tissue, providing an irradiance or intensity of
0.40 mW/cm2. The incidence of fluency range for eachFigure 5 Mandibular goniomenter equipment used in this
study.point of application will be of 12.0 J/cm2, and the irradi-
ation time of 30 seconds for each predetermined point.
Protocol for neuromuscular electrical stimulation (NMES)
NMES is a noninvasive technique, without systemic
effects, is not addictive and has no undesirable side
effects. This technique consists on the application of
mild electrical stimulation through electrodes placed on
the surface of muscles. It induces action potentials in
motor nerve, causing activation of motor units [30].
Effects such as strengthening the stimulated muscles, fa-
cilitation of voluntary motor control [31] and decreased
spasticity have been reported.
Neuromuscular electrical stimulation (Neurodyn III)
equipment will be used. In this study, a protocol will be
applied based on Nunes [32] recommendations, which are
sessions of 30 minutes (divided between the superficial
portion of masseter, the anterior portion of temporalis
muscle and supra-hyoid, according to the electromyogram
diagnosis), 2 times per week for 8 weeks compatible with
a total of NMES 16 sessions in patients of Groups 1, 4 and
5. After 8 weeks of NMES training, both neural and mus-
cular adaptations mediate the strength improvement .
Protocol for polysomnography
A full-night PSG [33] will be performed prior and after
all therapies, using a digital system (Embla, A10 version
3.1.2 Flaga, Hs. Medical Devices, Iceland) at the Sleep
Laboratory of University of Nove de Julho. All recording
sensors will be attached to the patient in a non-invasive
manner using tape or elastic bands. The following
physiological variables will be monitored simultaneously
and continuously: four channels for the electroenceph-
alogram (EEG) (C3-A2, C4-A1, O1-A2, O2-A1), two
channels for the electrooculogram (EOG) (EOG-Left-A2,
EOG-Right-A1), four channels for the surface electro-
myogram (muscles of the submentonian region, anterior
tibialis muscle, masseter region and seventh intercostal
space), one channel for an electrocardiogram (derivation
V1 modified), airflow detection via two channels through
a thermocouple (one channel) and nasal pressure (one
channel), respiratory effort of the thorax (one channel)
and the abdomen (one channel) via x-trace belts, snor-
ing (one channel) and body position (one channel) via
EMBLA sensors, and arterial oxygen saturation (SaO2)
and pulse rate via an EMBLA oximeter. All PSGs will be
performed and sleep stages visually scored according to
standardized criteria for investigating sleep. EEG arou-
sals, sleep-related respiratory events and leg movements
will be scored in accordance with the criteria established
by the American Academy of Sleep Medicine Manual
for Scoring Sleep and Associated Events [34]. The
patients will be instructed to remain as relaxed as pos-
sible and sleep naturally, as if at home. All signals will
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subjects will be monitored by a technician experienced
in polysomnography [33].
Quality control
In order to ensure data quality, dentists in charge of
EMG exam, as well as the speech-therapist in charge of
oral movements and sleep technician in charge of the
data acquisition of polysomnography will receive specific
training. Periodic external monitoring will be performed
to verify the adequate polysomnnographic examination.
The results of the preoperative and postoperative exams
will be analysed by blinded evaluators.
Statistical analysis
Data will be presented as means ± standard deviation,
when applicable. For comparison of continuous variables
prior and after polysomnography and specifics therapies,
it will be used the paired Student t-test or Wilcoxon
tests as appropriate. Comparisons between groups will
be performed using Student t test or Mann–Whitney U
according to the distribution. All tests will be 2 tailed,
and p values of less than 0.05 will be assumed to repre-
sent statistical significance. All analyses will be per-
formed using SPSS ver. 16.0.
Discussion
This study will evaluate the effects of lower power laser,
neuromuscular electrical stimulation, LED therapy, as
well as neuromuscular electrical stimulation plus LED
therapy and neuromuscular electrical stimulation plus
laser therapy on the masticatory muscles activity in
adults with CP, by means of surface electromyography.
We believe that electrical stimulation may act in the
modulation of muscle hyperactivity/hypoactivity, adjust-
ing them to a level close to normality. Also, we expect
the LED and laser morphophysiological favor recovery,
which will be observed clinically by the absence or re-
duction of pain. In addition, polysomnography will be
used to evaluate the sleep variables and to detect sleep-
breathing disorders, and we believe that the sleep quality
will be improved after therapies application.
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